Mai Pham, MD
Ophthalmology · Columbia, MONPI 1912171703
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 51.2% of the total. 2025 is the largest year on record at $10,091, 3.9 times the $2,591 reported in 2019. Among ophthalmology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $39.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$9K
- Johnson & Johnson Surgical Vision, Inc.$3K
- AbbVie$1K
- Glaukos Corporation$1K
- Alcon$781
- Harrow Eye, LLC$267
- plus $2K from 18 others
Across 1 payment — averaging $3937.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$4K
What the payments were for
- Consulting fees$1,65010%
- Speaking & faculty fees$7,05042%
- Travel & lodging$6044%
- Food & beverage$7,52145%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 195 | $8,632 |
| Johnson & Johnson Surgical Vision, Inc. | 11 | $2,782 |
| AbbVie(2 entities) | 79 | $1,345 |
| Glaukos Corporation | 4 | $1,251 |
| Alcon | 44 | $781 |
| Harrow Eye, LLC | 9 | $267 |
| Bausch & Lomb Americas Inc. | 13 | $235 |
| Oyster Point Pharma, Inc. | 8 | $232 |
| Kala Pharmaceuticals, Inc. | 19 | $210 |
| Dompe US, Inc. | 10 | $195 |
| Amgen(2 entities) | 7 | $169 |
| Boston Scientific | 2 | $107 |
| Aerie Pharmaceuticals, Inc. | 6 | $104 |
| TELA Bio, Inc. | 1 | $103 |
| Thea Pharma Inc. | 5 | $102 |
| Novartis | 6 | $99 |
| Tarsus Pharmaceuticals, Inc. | 2 | $58 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $43 |
| Sight Sciences, Inc. | 2 | $35 |
| Rxsight Inc | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Biotissue Holdings Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$6,541
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$1,650
- Tecnis 1-piece IOL$948
- Tecnis 3-piece IOL$948
- Tecnis Symphony IOL$948
- Tecnis Symphony Toric IOL$948
- iStent inject Trabecular Micro-Bypass Stent System$233
- VEVYE$143
- TRYPTYR$112
- iStent Trabecular Micro-Bypass Stent System$107
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$103
How this compares
$16,844 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 460 | $583,396 |
| CequaCyclosporine | 303 | $351,179 |
| LumiganBimatoprost | 514 | $284,641 |
| Cyclosporine | 235 | $179,966 |
| TyrvayaVarenicline Tartrate | 65 | $73,900 |
| XiidraLifitegrast | 34 | $45,896 |
| RhopressaNetarsudil Mesylate | 51 | $42,498 |
| MieboPerfluorohexyloctane/Pf | 31 | $28,826 |
| Alphagan PBrimonidine Tartrate | 54 | $22,704 |
| EysuvisLoteprednol Etabonate | 34 | $16,593 |
| VyzultaLatanoprostene Bunod | 31 | $15,907 |
| Prednisolone Acetate | 567 | $15,766 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 68 | $15,166 |
| Latanoprost | 725 | $10,765 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 34 | $10,195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P, Combigan | $1,345 | $897,8971,040 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $8,632 | $351,179303 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta | $235 | $90,62896 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $232 | $73,90065 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $104 | $42,49851 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $210 | $16,59334 claims |
| AlconSimbrinza | $781 | $10,19534 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate, Prolensa | $43 | $10,09063 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 286 ophthalmology providers in Missouri.
Other ophthalmology in Columbia
- Jella AnColumbia$166K
- John McCannColumbia$8K
- Steven SilversteinKansas City$872K
- Ranjan MalhotraSaint Louis$809K
- Nancy HolekampChesterfield$768K
- Jay PeposeChesterfield$516K
- Gregg BerdySaint Louis$360K
- Joseph GiraDes Peres$174K
- Joseph TauberKansas City$174K
- Shachar TauberSpringfield$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.